Found 6 matching trials
Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
PHASE4The objectives of this study were:
1. To demonstrate the efficacy/safety o...
Location
Hospital Universitari Bellvitge- Transplant Departments (Liver, Heart and Kidney)
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
PHASE2RATIONALE: The Epstein-Barr virus can cause cancer and lymphoproliferative ...
Location
Rebecca and John Moores UCSD Cancer Center
EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma
PHASE2Nearly all undifferentiated nasopharyngeal carcinoma (NPC) are associated w...
Location
Sun Yat-sen Universitty Cancer Center
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
PHASE1This open label study will assess the pharmacokinetics and the safety and t...
Location
Multiple Locations
Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)
PHASE4This study aims to determine: a) whether those patients with 'low level' vi...
Location
Royal Free London NHS Foundation Trust, Royal Free Hospital, Pond Street
A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections
PHASE3The main aim of this study is to learn how safe maribavir is in Chinese adu...
Location
Anhui Provincial Hospital(The First Affiliated Hospital of USTC)